LORAZEPAMRELATEDCOMPOUNDD(25MG)(6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLICACID)

LORAZEPAMRELATEDCOMPOUNDD(25MG)(6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLICACID) Basic Attributes

Characteristics

Safety Information

LORAZEPAMRELATEDCOMPOUNDD(25MG)(6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLICACID) Use and Manufacturing

Computed Properties

Latest News on LORAZEPAMRELATEDCOMPOUNDD(25MG)(6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINECAR-BOXYLICACID)

• Forecast and analysis of market size and entry barriers of China's pharmaceutical intermediates industry
• Pharmaceutical intermediates: the future development of adenine

Learn More Other Chemicals

• Methyl 1-(2,3-dihydroxypropyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2-pyridinecarboxylate

  1206102-07-9

• (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione

  1206102-10-4

• N-(2,3-dimethylphenyl)-2-methoxybenzamide

  331270-89-4

• (5Z)-1-(4-bromophenyl)-5-(furan-2-ylmethylidene)-3-phenyl-2-sulfanylidene-1,3-diazinane-4,6-dione Formula

  414908-02-4

• ethyl 2-[3-(trifluoromethyl)pyrazol-1-yl]acetate Formula

  380872-50-4

• N-(1-hydroxy-2-methylpropan-2-yl)-4-methoxybenzamide Formula

  94615-60-8

• 2-(1H-indol-3-yl)-N-(5-methyl-1,3-thiazol-2-yl)acetamide Structure

  784170-07-6

• 1-(4-tert-butylphenyl)sulfonyl-4-(2,5-dimethylphenyl)piperazine Structure

  693229-10-6

• What is 3-[(4-butylphenyl)sulfamoyl]benzoic acid

  377769-55-6

• What is 3H-thieno[2,3-d]pyrimidine-4-thione

  14080-55-8